Market Tracker

05/26 5:16pm ET

Novavax Inc (NASDAQ:NVAX)

0.99
Delayed Data
As of May 26
 -0.05 / -4.81%
Today’s Change
0.73
Today|||52-Week Range
8.49
-21.43%
Year-to-Date
Can The Uptrend Continue for Novavax (NVAX)?
May 26 / Zacks.com - Paid Partner Content
 

Today’s Trading

Previous close1.04
Today’s open1.03
Day’s range0.98 - 1.07
Volume4,375,677
Average volume (3 months)6,397,018
Market cap$279.8M
Dividend yield--
Data as of 3:59pm ET, 05/26/2017

Growth & Valuation

Earnings growth (last year)-71.67%
Earnings growth (this year)+40.40%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)-57.65%
P/E ratioNM
Price/Sales22.22
Price/Book--

Competitors

 Today’s
change
Today’s
% change
XBITXBiotech Inc-0.25-3.10%
RIGLRigel Pharmaceutical...-0.03-1.24%
SELBSelecta Biosciences ...+0.53+3.92%
KMDAKamada Ltd+0.05+0.70%
Data as of 3:59pm ET, 05/26/2017

Financials

Next reporting dateAugust 9, 2017
EPS forecast (this quarter)-$0.16
Annual revenue (last year)$15.4M
Annual profit (last year)-$280.0M
Net profit margin-1,823.53%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Stanley C. Erck
Chief Financial Officer, Treasurer &
Senior VP
Barclay A. Phillips
Corporate headquarters
Gaithersburg, Maryland

Forecasts